We also validated that curcumin enhances RT outcomes and boosts the anti-tumoral immune responses in bilateral CT26-luc tumor-bearing mice by performing a biodistribution study of 111In-DOTA-anti-OX40 mAb, ELISA assay, and Western blot. This evidence concerns the gene TNFRSF4 and neoplasm.